The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
The PD-1/PD-L1 Axis and Virus Infections: A Delicate Balance
Open accessAbstract
Programmed cell death protein (PD-1) and its ligands play a fundamental role in the evasion of tumor cells from antitumor immunity. Less well appreciated is the fact that the PD-1/PD-L1 axis also regulates antiviral immune responses and is therefore modulated by a number of viruses. Upregulation of PD-1 and its ligands PD-L1 and PD-L2 is observed during acute virus infection and after infection with persistent viruses including important human pathogens such as human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B virus (HBV). Experimental evidence suggests that insufficient signaling through the PD-1 pathway promotes immunopathology during acute infection by exaggerating primary T cell responses. If chronic infection is established, however, high levels of PD-1 expression can have unfavorable immunological consequences. Exhaustion and suppression of antiviral immune responses can result in viral immune evasion. The role of the PD-1/PD-L1 axis during viral infections is further complicated by evidence that PD-L1 also mediates inflammatory effects in the acute phase of an immune response. In this review, we discuss the intricate interplay between viruses and the PD-1/PD-L1 axis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846 · cited 2×
“Tcm cells lack effector functions but express lymph node homing molecules and circulate through the blood and the secondary lymphoid organs (Sallusto et al., 1999).”
BackgroundPD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
Ishida, Y., Agata, Y., Shibahara, K., & Honjo, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05481.x · Cited by 3,256
Molecular mechanisms of T cell co-stimulation and co-inhibition
Chen, L., & Flies, D. B. (2013) · Nature Reviews Immunology · doi:10.1038/nri3405 · Cited by 3,114
Nishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749
Schweitzer, A., Horn, J., Mikolajczyk, R. T., Krause, G., & Ott, J. J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61412-x · Cited by 2,742
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
The PD‐1 pathway in tolerance and autoimmunity
Francisco, L. M., Sage, P. T., & Sharpe, A. H. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00923.x · Cited by 2,300
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
Regulation and Function of the PD-L1 Checkpoint
Sun, C., Mezzadra, R., & Schumacher, T. N. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.014 · Cited by 2,193
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., & Sharpe, A. H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090847 · Cited by 2,079
Blackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A., Betts, M. R., Freeman, G. J., Vignali, D. A. A., & Wherry, E. J. (2009) · Nature Immunology · doi:10.1038/ni.1679 · Cited by 2,062
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
The diverse functions of the PD1 inhibitory pathway
Sharpe, A. H., & Pauken, K. E. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.108 · Cited by 1,971
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Garcia-Diaz, A., Shin, D. S., Moreno, B. H., Saco, J., Escuin-Ordinas, H., Rodriguez, G. A., Zaretsky, J. M., Sun, L., Hugo, W., Wang, X., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.031 · Cited by 1,942
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A., & Hymowitz, S. G. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101312 · Cited by 1,925
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Ott, J. J., Stevens, G. A., Groeger, J., & Wiersma, S. T. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.116 · Cited by 1,843
Butte, M. J., Keir, M. E., Phamduy, T. B., Sharpe, A. H., & Freeman, G. J. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.016 · Cited by 1,732
Wherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most, R., & Ahmed, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4911-4927.2003 · Cited by 1,610
Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes
Agata, Y., Kawasaki, A., Nishimura, H., Ishida, Y., Tsubat, T., Yagita, H., & Honjo, T. (1996) · International Immunology · doi:10.1093/intimm/8.5.765 · Cited by 1,589
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M.-R., Delwart, E., Sepulveda, H., Balderas, R. S., et al. (2006) · Nature Medicine · doi:10.1038/nm1482 · Cited by 1,565
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection
Sharpe, A. H., Wherry, E. J., Ahmed, R., & Freeman, G. J. (2007) · Nature Immunology · doi:10.1038/ni1443 · Cited by 1,528
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
Sanmamed, M. F., & Chen, L. (2018) · Cell · doi:10.1016/j.cell.2018.09.035 · Cited by 1,392
Stanaway, J. D., Flaxman, A. D., Naghavi, M., Fitzmaurice, C., Vos, T., Abubakar, I., Abu-Raddad, L. J., Assadi, R., Bhala, N., Cowie, B., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30579-7 · Cited by 1,358
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.006 · Cited by 1,354
Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
Pauken, K. E., Sammons, M. A., Odorizzi, P. M., Manne, S., Godec, J., Khan, O., Drake, A. M., Chen, Z., Sen, D. R., Kurachi, M., et al. (2016) · Science · doi:10.1126/science.aaf2807 · Cited by 1,348 · cited 2×
“Reinvigorated CD8+ T cells in chronically LCMV-infected mice become exhausted again after termination of the PD-L1 blockade (Pauken et al., 2016; Sen et al., 2016; Turner and Russ, 2016).”
BackgroundResultBlockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., et al. (2003) · Nature Medicine · doi:10.1038/nm863 · Cited by 1,314
Moskophidis, D., Lechner, F., Pircher, H., & Zinkernagel, R. M. (1993) · Nature · doi:10.1038/362758a0 · Cited by 1,240
Tissue expression of PD-L1 mediates peripheral T cell tolerance
Keir, M. E., Liang, S. C., Guleria, I., Latchman, Y. E., Qipo, A., Albacker, L. A., Koulmanda, M., Freeman, G. J., Sayegh, M. H., & Sharpe, A. H. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051776 · Cited by 1,211
Homeostasis of Naive and Memory T Cells
Surh, C. D., & Sprent, J. (2008) · Immunity · doi:10.1016/j.immuni.2008.11.002 · Cited by 1,193
Gebhardt, T., Wakim, L. M., Eidsmo, L., Reading, P. C., Heath, W. R., & Carbone, F. R. (2009) · Nature Immunology · doi:10.1038/ni.1718 · Cited by 1,157
CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection
Matloubian, M., Concepcion, R. J., & Ahmed, R. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8056-8063.1994 · Cited by 1,157
Shared and Distinct Functions of Type I and Type III Interferons
Lazear, H. M., Schoggins, J. W., & Diamond, M. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.025 · Cited by 1,138
CD8+ T Cells: Foot Soldiers of the Immune System
Zhang, N., & Bevan, M. J. (2011) · Immunity · doi:10.1016/j.immuni.2011.07.010 · Cited by 1,088
Kumar, B. V., Ma, W., Miron, M., Granot, T., Guyer, R. S., Carpenter, D. J., Senda, T., Sun, X., Ho, S.-H., Lerner, H., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.078 · Cited by 1,068
Redefining Chronic Viral Infection
Virgin, H. W., Wherry, E. J., & Ahmed, R. (2009) · Cell · doi:10.1016/j.cell.2009.06.036 · Cited by 1,031
The epigenetic landscape of T cell exhaustion
Sen, D. R., Kaminski, J., Barnitz, R. A., Kurachi, M., Gerdemann, U., Yates, K. B., Tsao, H.-W., Godec, J., LaFleur, M. W., Brown, F. D., et al. (2016) · Science · doi:10.1126/science.aae0491 · Cited by 986
Brown, J. A., Dorfman, D. M., Ma, F.-R., Sullivan, E. L., Munoz, O., Wood, C. R., Greenfield, E. A., & Freeman, G. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1257 · Cited by 968
Kolumam, G. A., Thomas, S., Thompson, L. J., Sprent, J., & Murali-Krishna, K. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050821 · Cited by 965
Expression of Programmed Death 1 Ligands by Murine T Cells and APC
Yamazaki, T., Akiba, H., Iwai, H., Matsuda, H., Aoki, M., Tanno, Y., Shin, T., Tsuchiya, H., Pardoll, D. M., Okumura, K., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5538 · Cited by 951
CD28 Costimulation: From Mechanism to Therapy
Esensten, J. H., Helou, Y. A., Chopra, G., Weiss, A., & Bluestone, J. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.020 · Cited by 937 · cited 1×
“These molecules counterbalance co-stimulatory receptors on T cells such as CD28, which bind to CD80 and CD86 on professional APCs and facilitate T cell activation (Esensten et al., 2016).”
BackgroundInterleukin-10 determines viral clearance or persistence in vivo
Brooks, D. G., Trifilo, M. J., Edelmann, K. H., Teyton, L., McGavern, D. B., & Oldstone, M. B. A. (2006) · Nature Medicine · doi:10.1038/nm1492 · Cited by 923
Okazaki, T., Chikuma, S., Iwai, Y., Fagarasan, S., & Honjo, T. (2013) · Nature Immunology · doi:10.1038/ni.2762 · Cited by 916
Progenitor and Terminal Subsets of CD8 + T Cells Cooperate to Contain Chronic Viral Infection
Paley, M. A., Kroy, D. C., Odorizzi, P. M., Johnnidis, J. B., Dolfi, D. V., Barnett, B. E., Bikoff, E. K., Robertson, E. J., Lauer, G. M., Reiner, S. L., et al. (2012) · Science · doi:10.1126/science.1229620 · Cited by 902
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection
Petrovas, C., Casazza, J. P., Brenchley, J. M., Price, D. A., Gostick, E., Adams, W. C., Precopio, M. L., Schacker, T., Roederer, M., Douek, D. C., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061496 · Cited by 889
Bengsch, B., Johnson, A. L., Kurachi, M., Odorizzi, P. M., Pauken, K. E., Attanasio, J., Stelekati, E., McLane, L. M., Paley, M. A., Delgoffe, G. M., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.008 · Cited by 868 · cited 1×
“Intriguingly, PD-1-regulated changes in several metabolic pathways occur at the very beginning of Tex cell development underlining the importance of these metabolic processes in the execution of the Tex program (Bengsch et al., 2016; Schurich et al., 2016; McKinney and Smith, 2018).”
BackgroundMemory CD8 T-Cell Differentiation during Viral Infection
Wherry, E. J., & Ahmed, R. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5535-5545.2004 · Cited by 868
Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection
Jin, H.-T., Anderson, A. C., Tan, W. G., West, E. E., Ha, S.-J., Araki, K., Freeman, G. J., Kuchroo, V. K., & Ahmed, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009731107 · Cited by 858
Enhancing SIV-specific immunity in vivo by PD-1 blockade
Velu, V., Titanji, K., Zhu, B., Husain, S., Pladevega, A., Lai, L., Vanderford, T. H., Chennareddi, L., Silvestri, G., Freeman, G. J., et al. (2009) · Nature · doi:10.1038/nature07662 · Cited by 771
Gallimore, A., Glithero, A., Godkin, A., Tissot, A. C., Plückthun, A., Elliott, T., Hengartner, H., & Zinkernagel, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1383 · Cited by 763
Persistent LCMV infection is controlled by blockade of type I interferon signaling
Teijaro, J. R., Ng, C., Lee, A. M., Sullivan, B. M., Sheehan, K. C. F., Welch, M., Schreiber, R. D., Carlos de la Torre, J., & Oldstone, M. B. A. (2013) · Science · doi:10.1126/science.1235214 · Cited by 755
Resident memory CD8 T cells trigger protective innate and adaptive immune responses
Schenkel, J. M., Fraser, K. A., Beura, L. K., Pauken, K. E., Vezys, V., & Masopust, D. (2014) · Science · doi:10.1126/science.1254536 · Cited by 731
The PD-1–PD-L pathway in immunological tolerance
Okazaki, T., & Honjo, T. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.02.001 · Cited by 721
Blockade of chronic type I interferon signaling to control persistent LCMV infection
Wilson, E. B., Yamada, D. H., Elsaesser, H., Herskovitz, J., Deng, J., Cheng, G., Aronow, B. J., Karp, C. L., & Brooks, D. G. (2013) · Science · doi:10.1126/science.1235208 · Cited by 709
CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions
Hashimoto, M., Kamphorst, A. O., Im, S. J., Kissick, H. T., Pillai, R. N., Ramalingam, S. S., Araki, K., & Ahmed, R. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-012017-043208 · Cited by 656
Location, location, location: Tissue resident memory T cells in mice and humans
Szabo, P. A., Miron, M., & Farber, D. L. (2019) · Science Immunology · doi:10.1126/sciimmunol.aas9673 · Cited by 651
Sensing and alarm function of resident memory CD8+ T cells
Schenkel, J. M., Fraser, K. A., Vezys, V., & Masopust, D. (2013) · Nature Immunology · doi:10.1038/ni.2568 · Cited by 640
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells
Loke, P., & Allison, J. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931259100 · Cited by 634
Dynamic T cell migration program provides resident memory within intestinal epithelium
Masopust, D., Choo, D., Vezys, V., Wherry, E. J., Duraiswamy, J., Akondy, R., Wang, J., Casey, K. A., Barber, D. L., Kawamura, K. S., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20090858 · Cited by 628
Wang, H., Wolock, T. M., Carter, A., Nguyen, G., Kyu, H. H., Gakidou, E., Hay, S. I., Mills, E. J., Trickey, A., Msemburi, W., et al. (2016) · The Lancet HIV · doi:10.1016/s2352-3018(16)30087-x · Cited by 613
Immune checkpoint blockade in infectious diseases
Wykes, M. N., & Lewin, S. R. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.112 · Cited by 570
Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4
Probst, H. C., McCoy, K., Okazaki, T., Honjo, T., & van den Broek, M. (2005) · Nature Immunology · doi:10.1038/ni1165 · Cited by 554
Doering, T. A., Crawford, A., Angelosanto, J. M., Paley, M. A., Ziegler, C. G., & Wherry, E. J. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.021 · Cited by 548
Resolution of a chronic viral infection after interleukin-10 receptor blockade
Ejrnaes, M., Filippi, C. M., Martinic, M. M., Ling, E. M., Togher, L. M., Crotty, S., & von Herrath, M. G. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061462 · Cited by 548
Skin-resident memory CD8 + T cells trigger a state of tissue-wide pathogen alert
Ariotti, S., Hogenbirk, M. A., Dijkgraaf, F. E., Visser, L. L., Hoekstra, M. E., Song, J.-Y., Jacobs, H., Haanen, J. B., & Schumacher, T. N. (2014) · Science · doi:10.1126/science.1254803 · Cited by 533
Origin and differentiation of human memory CD8 T cells after vaccination
Akondy, R. S., Fitch, M., Edupuganti, S., Yang, S., Kissick, H. T., Li, K. W., Youngblood, B. A., Abdelsamed, H. A., McGuire, D. J., Cohen, K. W., et al. (2017) · Nature · doi:10.1038/nature24633 · Cited by 517
Man, K., Gabriel, S. S., Liao, Y., Gloury, R., Preston, S., Henstridge, D. C., Pellegrini, M., Zehn, D., Berberich-Siebelt, F., Febbraio, M. A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.11.021 · Cited by 506
Antigen-independent memory CD8 T cells do not develop during chronic viral infection
Wherry, E. J., Barber, D. L., Kaech, S. M., Blattman, J. N., & Ahmed, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407192101 · Cited by 497
Molecular and Transcriptional Basis of CD4+ T Cell Dysfunction during Chronic Infection
Crawford, A., Angelosanto, J. M., Kao, C., Doering, T. A., Odorizzi, P. M., Barnett, B. E., & Wherry, E. J. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.005 · Cited by 496
Galani, I. E., Triantafyllia, V., Eleminiadou, E.-E., Koltsida, O., Stavropoulos, A., Manioudaki, M., Thanos, D., Doyle, S. E., Kotenko, S. V., Thanopoulou, K., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.025 · Cited by 477
Role of PD-1 during effector CD8 T cell differentiation
Ahn, E., Araki, K., Hashimoto, M., Li, W., Riley, J. L., Cheung, J., Sharpe, A. H., Freeman, G. J., Irving, B. A., & Ahmed, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718217115 · Cited by 474
Effector CD8 T cells dedifferentiate into long-lived memory cells
Youngblood, B., Hale, J. S., Kissick, H. T., Ahn, E., Xu, X., Wieland, A., Araki, K., West, E. E., Ghoneim, H. E., Fan, Y., et al. (2017) · Nature · doi:10.1038/nature25144 · Cited by 471
Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells
Odorizzi, P. M., Pauken, K. E., Paley, M. A., Sharpe, A., & Wherry, E. J. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142237 · Cited by 467
Programs for the persistence, vigilance and control of human CD8+ lung-resident memory T cells
Hombrink, P., Helbig, C., Backer, R. A., Piet, B., Oja, A. E., Stark, R., Brasser, G., Jongejan, A., Jonkers, R. E., Nota, B., et al. (2016) · Nature Immunology · doi:10.1038/ni.3589 · Cited by 455
Dendritic Cell-Induced Memory T Cell Activation in Nonlymphoid Tissues
Wakim, L. M., Waithman, J., van Rooijen, N., Heath, W. R., & Carbone, F. R. (2008) · Science · doi:10.1126/science.1151869 · Cited by 445
Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes
Wang, J., Yoshida, T., Nakaki, F., Hiai, H., Okazaki, T., & Honjo, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505497102 · Cited by 437
Youngblood, B., Oestreich, K. J., Ha, S.-J., Duraiswamy, J., Akondy, R. S., West, E. E., Wei, Z., Lu, P., Austin, J. W., Riley, J. L., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.06.015 · Cited by 419
Brett, J., Gerlach, H., Nawroth, P., Steinberg, S., Godman, G., & Stern, D. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.6.1977 · Cited by 409
Tissue-resident memory T cells populate the human brain
Smolders, J., Heutinck, K. M., Fransen, N. L., Remmerswaal, E. B. M., Hombrink, P., ten Berge, I. J. M., van Lier, R. A. W., Huitinga, I., & Hamann, J. (2018) · Nature Communications · doi:10.1038/s41467-018-07053-9 · Cited by 406
Khanna, K. M., Bonneau, R. H., Kinchington, P. R., & Hendricks, R. L. (2003) · Immunity · doi:10.1016/s1074-7613(03)00112-2 · Cited by 402
PD-1 Inhibits Antiviral Immunity at the Effector Phase in the Liver
Iwai, Y., Terawaki, S., Ikegawa, M., Okazaki, T., & Honjo, T. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022235 · Cited by 392
Sugiura, D., Maruhashi, T., Okazaki, I.-M., Shimizu, K., Maeda, T. K., Takemoto, T., & Okazaki, T. (2019) · Science · doi:10.1126/science.aav7062 · Cited by 386
Liu, T., Khanna, K. M., Chen, X., Fink, D. J., & Hendricks, R. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.9.1459 · Cited by 385
Staron, M. M., Gray, S. M., Marshall, H. D., Parish, I. A., Chen, J. H., Perry, C. J., Cui, G., Li, M. O., & Kaech, S. M. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.013 · Cited by 385
Mühlbauer, M., Fleck, M., Schütz, C., Weiss, T., Froh, M., Blank, C., Schölmerich, J., & Hellerbrand, C. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.007 · Cited by 378
Guarding the frontiers: the biology of type III interferons
Wack, A., Terczyńska-Dyla, E., & Hartmann, R. (2015) · Nature Immunology · doi:10.1038/ni.3212 · Cited by 364
The role of the PD‐1 pathway in autoimmunity and peripheral tolerance
Fife, B. T., & Pauken, K. E. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05919.x · Cited by 355
Saeidi, A., Zandi, K., Cheok, Y. Y., Saeidi, H., Wong, W. F., Lee, C. Y. Q., Cheong, H. C., Yong, Y. K., Larsson, M., & Shankar, E. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02569 · Cited by 350
IL-2high tissue-resident T cells in the human liver: Sentinels for hepatotropic infection
Pallett, L. J., Davies, J., Colbeck, E. J., Robertson, F., Hansi, N., Easom, N. J. W., Burton, A. R., Stegmann, K. A., Schurich, A., Swadling, L., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162115 · Cited by 347
Terawaki, S., Chikuma, S., Shibayama, S., Hayashi, T., Yoshida, T., Okazaki, T., & Honjo, T. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003208 · Cited by 342
T cell exhaustion during persistent viral infections
Kahan, S. M., Wherry, E. J., & Zajac, A. J. (2015) · Virology · doi:10.1016/j.virol.2014.12.033 · Cited by 324
Xiao, Y., Yu, S., Zhu, B., Bedoret, D., Bu, X., Francisco, L. M., Hua, P., Duke-Cohan, J. S., Umetsu, D. T., Sharpe, A. H., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20130790 · Cited by 321
Pathogenesis of the Viral Hemorrhagic Fevers
Paessler, S., & Walker, D. H. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-164041 · Cited by 309
Human Ebola virus infection results in substantial immune activation
McElroy, A. K., Akondy, R. S., Davis, C. W., Ellebedy, A. H., Mehta, A. K., Kraft, C. S., Lyon, G. M., Ribner, B. S., Varkey, J., Sidney, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502619112 · Cited by 306
Strength of PD-1 signaling differentially affects T-cell effector functions
Wei, F., Zhong, S., Ma, Z., Kong, H., Medvec, A., Ahmed, R., Freeman, G. J., Krogsgaard, M., & Riley, J. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305394110 · Cited by 304
T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion?
Speiser, D. E., Utzschneider, D. T., Oberle, S. G., Münz, C., Romero, P., & Zehn, D. (2014) · Nature Reviews Immunology · doi:10.1038/nri3740 · Cited by 302
T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion
Utzschneider, D. T., Legat, A., Fuertes Marraco, S. A., Carrié, L., Luescher, I., Speiser, D. E., & Zehn, D. (2013) · Nature Immunology · doi:10.1038/ni.2606 · Cited by 283
Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection
Shin, H., Blackburn, S. D., Blattman, J. N., & Wherry, E. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061937 · Cited by 273
Selenko-Gebauer, N., Majdic, O., Szekeres, A., Höfler, G., Guthann, E., Korthäuer, U., Zlabinger, G., Steinberger, P., Pickl, W. F., Stockinger, H., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3637 · Cited by 263
PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis
Zinselmeyer, B. H., Heydari, S., Sacristán, C., Nayak, D., Cammer, M., Herz, J., Cheng, X., Davis, S. J., Dustin, M. L., & McGavern, D. B. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121416 · Cited by 258
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease
Attanasio, J., & Wherry, E. J. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.022 · Cited by 256
Schurich, A., Pallett, L. J., Jajbhay, D., Wijngaarden, J., Otano, I., Gill, U. S., Hansi, N., Kennedy, P. T., Nastouli, E., Gilson, R., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.078 · Cited by 256
Legat, A., Speiser, D. E., Pircher, H., Zehn, D., & Fuertes Marraco, S. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00455 · Cited by 250
Honda, T., Egen, J. G., Lämmermann, T., Kastenmüller, W., Torabi-Parizi, P., & Germain, R. N. (2014) · Immunity · doi:10.1016/j.immuni.2013.11.017 · Cited by 237
Verjans, G. M. G. M., Hintzen, R. Q., van Dun, J. M., Poot, A., Milikan, J. C., Laman, J. D., Langerak, A. W., Kinchington, P. R., & Osterhaus, A. D. M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610847104 · Cited by 233
Maier, H., Isogawa, M., Freeman, G. J., & Chisari, F. V. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2714 · Cited by 232
Role of regulatory T cells during virus infection
Veiga‐Parga, T., Sehrawat, S., & Rouse, B. T. (2013) · Immunological Reviews · doi:10.1111/imr.12085 · Cited by 232
PD-1-Mediated Suppression of IL-2 Production Induces CD8+ T Cell Anergy In Vivo
Chikuma, S., Terawaki, S., Hayashi, T., Nabeshima, R., Yoshida, T., Shibayama, S., Okazaki, T., & Honjo, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900080 · Cited by 231
Interaction of human PD-L1 and B7-1
Butte, M. J., Peña-Cruz, V., Kim, M.-J., Freeman, G. J., & Sharpe, A. H. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.05.014 · Cited by 228
Brooks, D. G., Ha, S.-J., Elsaesser, H., Sharpe, A. H., Freeman, G. J., & Oldstone, M. B. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811139106 · Cited by 220
Wieland, D., Kemming, J., Schuch, A., Emmerich, F., Knolle, P., Neumann-Haefelin, C., Held, W., Zehn, D., Hofmann, M., & Thimme, R. (2017) · Nature Communications · doi:10.1038/ncomms15050 · Cited by 213
Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice
Frebel, H., Nindl, V., Schuepbach, R. A., Braunschweiler, T., Richter, K., Vogel, J., Wagner, C. A., Loffing-Cueni, D., Kurrer, M., Ludewig, B., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20121015 · Cited by 209
Targeting the Function of Mature Dendritic Cells by Human Cytomegalovirus
Raftery, M. J., Schwab, M., Eibert, S. M., Samstag, Y., Walczak, H., & Schönrich, G. (2001) · Immunity · doi:10.1016/s1074-7613(01)00239-4 · Cited by 208
Self-citationViral acute lower respiratory infections impair CD8+ T cells through PD-1
Erickson, J. J., Gilchuk, P., Hastings, A. K., Tollefson, S. J., Johnson, M., Downing, M. B., Boyd, K. L., Johnson, J. E., Kim, A. S., Joyce, S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62860 · Cited by 203
IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells
Sun, Z., Fourcade, J., Pagliano, O., Chauvin, J.-M., Sander, C., Kirkwood, J. M., & Zarour, H. M. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3016 · Cited by 198
Disease-Promoting Effects of Type I Interferons in Viral, Bacterial, and Coinfections
Davidson, S., Maini, M. K., & Wack, A. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0227 · Cited by 196
Unique human immune signature of Ebola virus disease in Guinea
Ruibal, P., Oestereich, L., Lüdtke, A., Becker-Ziaja, B., Wozniak, D. M., Kerber, R., Korva, M., Cabeza-Cabrerizo, M., Bore, J. A., Koundouno, F. R., et al. (2016) · Nature · doi:10.1038/nature17949 · Cited by 182
PD-L1 Binds to B7-1 Only In Cis on the Same Cell Surface
Chaudhri, A., Xiao, Y., Klee, A. N., Wang, X., Zhu, B., & Freeman, G. J. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0316 · Cited by 180
Hantavirus‐induced immunity in rodent reservoirs and humans
Schönrich, G., Rang, A., Lütteke, N., Raftery, M. J., Charbonnel, N., & Ulrich, R. G. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00694.x · Cited by 178
Self-citationUtzschneider, D. T., Alfei, F., Roelli, P., Barras, D., Chennupati, V., Darbre, S., Delorenzi, M., Pinschewer, D. D., & Zehn, D. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20150598 · Cited by 174
Aichele, P., Unsoeld, H., Koschella, M., Schweier, O., Kalinke, U., & Vucikuja, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4525 · Cited by 172
Unexpected protective role for Toll-like receptor 3 in the arterial wall
Cole, J. E., Navin, T. J., Cross, A. J., Goddard, M. E., Alexopoulou, L., Mitra, A. T., Davies, A. H., Flavell, R. A., Feldmann, M., & Monaco, C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018515108 · Cited by 170
IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer
Lamichhane, P., Karyampudi, L., Shreeder, B., Krempski, J., Bahr, D., Daum, J., Kalli, K. R., Goode, E. L., Block, M. S., Cannon, M. J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0740 · Cited by 170
Okabayashi, T., Kojima, T., Masaki, T., Yokota, S.-I., Imaizumi, T., Tsutsumi, H., Himi, T., Fujii, N., & Sawada, N. (2011) · Virus Research · doi:10.1016/j.virusres.2011.07.011 · Cited by 165
Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options
Velu, V., Shetty, R. D., Larsson, M., & Shankar, E. M. (2015) · Retrovirology · doi:10.1186/s12977-015-0144-x · Cited by 160
Mueller, S. N., Vanguri, V. K., Ha, S.-J., West, E. E., Keir, M. E., Glickman, J. N., Sharpe, A. H., & Ahmed, R. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40040 · Cited by 160
McKendry, R., Spalluto, C. M., Burke, H., Nicholas, B., Cellura, D., Al‐Shamkhani, A., Staples, K. J., & Wilkinson, T. M. A. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0782oc · Cited by 159
Human memory CD8 T cell effector potential is epigenetically preserved during in vivo homeostasis
Abdelsamed, H. A., Moustaki, A., Fan, Y., Dogra, P., Ghoneim, H. E., Zebley, C. C., Triplett, B. M., Sékaly, R., & Youngblood, B. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161760 · Cited by 155
Shp-2 Is Dispensable for Establishing T Cell Exhaustion and for PD-1 Signaling In Vivo
Rota, G., Niogret, C., Dang, A. T., Barros, C. R., Fonta, N. P., Alfei, F., Morgado, L., Zehn, D., Birchmeier, W., Vivier, E., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.026 · Cited by 155
Role of PD-1 in regulating acute infections
Brown, K. E., Freeman, G. J., Wherry, E. J., & Sharpe, A. H. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.03.007 · Cited by 147
Immunopathology of highly virulent pathogens: insights from Ebola virus
Zampieri, C. A., Sullivan, N. J., & Nabel, G. J. (2007) · Nature Immunology · doi:10.1038/ni1519 · Cited by 146
Brooks, D. G. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26856 · Cited by 145
Impact of Epitope Escape on PD-1 Expression and CD8 T-Cell Exhaustion during Chronic Infection
Blattman, J. N., Wherry, E. J., Ha, S., der Most, R. G. V., & Ahmed, R. (2009) · Journal of Virology · doi:10.1128/jvi.02524-08 · Cited by 143
Shaping Phenotype, Function, and Survival of Dendritic Cells by Cytomegalovirus-Encoded IL-10
Raftery, M. J., Wieland, D. I., Gronewald, S., Kraus, A., Giese, T., & Schönrich, G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3383 · Cited by 139
Self-citationRutigliano, J. A., Sharma, S., Morris, M. Y., Oguin, T. H., McClaren, J. L., Doherty, P. C., & Thomas, P. G. (2013) · Journal of Virology · doi:10.1128/jvi.02851-13 · Cited by 138
Mouse models of acute and chronic hepacivirus infection
Billerbeck, E., Wolfisberg, R., Fahnøe, U., Xiao, J., Quirk, C., Luna, J. M., Cullen, J. M., Hartlage, A. S., Chiriboga, L. A., Ghoshal, K., et al. (2017) · Science · doi:10.1126/science.aal1962 · Cited by 136
Allen, S. J., Hamrah, P., Gate, D., Mott, K. R., Mantopoulos, D., Zheng, L., Town, T., Jones, C., von Andrian, U. H., Freeman, G. J., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02290-10 · Cited by 132
Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs
Zanoni, I., Granucci, F., & Broggi, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01661 · Cited by 130
PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation
Petrelli, A., Mijnheer, G., van Konijnenburg, D. P. H., van der Wal, M. M., Giovannone, B., Mocholi, E., Vazirpanah, N., Broen, J. C., Hijnen, D., Oldenburg, B., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96107 · Cited by 126
Matloubian, M., Somasundaram, T., Kolhekar, S. R., Selvakumar, R., & Ahmed, R. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.4.1043 · Cited by 123
Putting the Immunologic Brakes on Cancer
Wolchok, J. D. (2018) · Cell · doi:10.1016/j.cell.2018.11.006 · Cited by 123
Pulko, V., Liu, X., Krco, C. J., Harris, K. J., Frigola, X., Kwon, E. D., & Dong, H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900974 · Cited by 122
Upregulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands
Meier, A., Bagchi, A., Sidhu, H. K., Alter, G., Suscovich, T. J., Kavanagh, D. G., Streeck, H., Brockman, M. A., Gall, S. L., Hellman, J., et al. (2008) · AIDS · doi:10.1097/qad.0b013e3282f4de23 · Cited by 121
Metabolic exhaustion in infection, cancer and autoimmunity
McKinney, E. F., & Smith, K. G. C. (2018) · Nature Immunology · doi:10.1038/s41590-018-0045-y · Cited by 119
Herpes Simplex Virus Type 1 Infection of Activated Cytotoxic T Cells
Raftery, M. J., Behrens, C. K., Müller, A., Krammer, P. H., Walczak, H., & Schönrich, G. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.8.1103 · Cited by 116
Self-citationNg, C. T., Snell, L. M., Brooks, D. G., & Oldstone, M. B. A. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.05.014 · Cited by 115
Rodríguez‐García, M., Porichis, F., de Jong, O. G., Levi, K., Diefenbach, T. J., Lifson, J. D., Freeman, G. J., Walker, B. D., Kaufmann, D., & Kavanagh, D. G. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0610327 · Cited by 111
Koh, K. P., Wang, Y., Yi, T., Shiao, S. L., Lorber, M. I., Sessa, W. C., Tellides, G., & Pober, J. S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21767 · Cited by 108
Hepatitis C Virus Core Protein Subverts the Antiviral Activities of Human Kupffer Cells
Tu, Z., Pierce, R. H., Kurtis, J. D., Kuroki, Y., Crispe, I. N., & Orloff, M. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.009 · Cited by 106
Molecular pathogenesis of viral hemorrhagic fever
Basler, C. F. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0637-x · Cited by 106
Lymphocytic Choriomeningitis Virus (LCMV): Propagation, Quantitation, and Storage
Welsh, R. M., & Seedhom, M. O. (2008) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc15a01s8 · Cited by 104
Inhibitory checkpoint receptors control CD8+ resident memory T cells to prevent skin allergy
Gamradt, P., Laoubi, L., Nosbaum, A., Mutez, V., Lenief, V., Grande, S., Redoules, D., Schmitt, A.-M., Nicolas, J., & Vocanson, M. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.11.048 · Cited by 104
Longitudinal Analysis of the Human T Cell Response during Acute Hantavirus Infection
Lindgren, T., Ahlm, C., Mohamed, N., Evander, M., Ljunggren, H., & Björkström, N. K. (2011) · Journal of Virology · doi:10.1128/jvi.05548-11 · Cited by 101
Long-Term Persistence of Exhausted CD8 T Cells in Chronic Infection Is Regulated by MicroRNA-155
Stelekati, E., Chen, Z., Manne, S., Kurachi, M., Ali, M.-A., Lewy, K., Cai, Z., Nzingha, K., McLane, L. M., Hope, J. L., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.038 · Cited by 101
Detrimental Contribution of the Immuno-Inhibitor B7-H1 to Rabies Virus Encephalitis
Lafon, M., Mégret, F., Meuth, S. G., Simon, O. J., Velandia-Romero, M. L., Lafage, M., Chen, L., Alexopoulou, L., Flavell, R. A., Prehaud, C. J. N., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7506 · Cited by 100
Stanciu, L. A., Bellettato, C. M., Laza‐Stanca, V., Coyle, A. J., Papi, A. A., & Johnston, S. L. (2006) · The Journal of Infectious Diseases · doi:10.1086/499275 · Cited by 99
Benedict, C. A., Loewendorf, A. I., Garcia, Z., Blazar, B. R., & Janssen, E. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4836 · Cited by 95
Type III interferon signaling restricts enterovirus 71 infection of goblet cells
Good, C. A., Wells, A. I., & Coyne, C. B. (2019) · Science Advances · doi:10.1126/sciadv.aau4255 · Cited by 95
T cell exhaustion and immune-mediated disease — the potential for therapeutic exhaustion
McKinney, E. F., & Smith, K. G. C. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.09.005 · Cited by 94
Combination anti–PD-1 and antiretroviral therapy provides therapeutic benefit against SIV
Mylvaganam, G., Chea, L. S., Tharp, G. K., Hicks, S. L., Velu, V., Iyer, S. S., Deléage, C., Estes, J. D., Bosinger, S. E., Freeman, G. J., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.122940 · Cited by 92
Chentoufi, A. A., Serafin, E. K., Tran, M. V., Dasgupta, G., Lim, C. H., Yu, D. C., Afifi, R. E., Jiang, X., Carpenter, D., Osorio, N., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00587-11 · Cited by 90
Ouyang, P., Rakus, K. Ł., van Beurden, S. J., Westphal, A. H., Davison, A. J., Gatherer, D., & Vanderplasschen, A. F. C. (2013) · Journal of General Virology · doi:10.1099/vir.0.058966-0 · Cited by 88
Host, K. M., Jacobs, S. R., West, J. A., Zhang, Z., Costantini, L. M., Stopford, C. M., Dittmer, D. P., & Damania, B. (2017) · mBio · doi:10.1128/mbio.00917-17 · Cited by 88
Varicella-Zoster Virus T Cell Tropism and the Pathogenesis of Skin Infection
Arvin, A. M., Moffat, J. F., Sommer, M. H., Oliver, S. L., Che, X., Vleck, S. E., Zerboni, L., & Ku, C. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_29 · Cited by 87
Telcian, A. G., Laza‐Stanca, V., Edwards, M. R., Harker, J. A., Wang, H., Bartlett, N. W., Mallia, P., Zdrenghea, M., Kebadze, T., Coyle, A. J., et al. (2010) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq020 · Cited by 81
Mackay, L. K., Wakim, L. M., van Vliet, C., Jones, C. M., Mueller, S. N., Bannard, O., Fearon, D. T., Heath, W. R., & Carbone, F. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102719 · Cited by 79
Recent advances in viral evasion of the MHC Class I processing pathway
Schuren, A. B. C., Costa, A. I., & Wiertz, E. J. H. J. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.02.007 · Cited by 77
Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract
Andreakos, E., Salagianni, M. L., Galani, I. E., & Koltsida, O. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01232 · Cited by 77
Innate Immune Responses to LCMV Infections: Natural Killer Cells and Cytokines
Biron, C. A., Nguyen, K. B., & Pien, G. C. (2002) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-56055-2_2 · Cited by 76
McNally, B. A., Ye, F., Willette, M., & Flaño, E. (2013) · Journal of Virology · doi:10.1128/jvi.02423-13 · Cited by 74
Boasso, A., Hardy, A. W., LANDAY, A. L., Martinson, J., Anderson, S. A., Dolan, M. J., Clerici, M., & Shearer, G. M. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.05.009 · Cited by 73
Maintenance of PD‐1 on brain‐resident memory CD8 T cells is antigen independent
Shwetank, Abdelsamed, H. A., Frost, E. L., Schmitz, H. M., Mockus, T. E., Youngblood, B., & Lukacher, A. E. (2017) · Immunology and Cell Biology · doi:10.1038/icb.2017.62 · Cited by 73
TLR3 triggering regulates PD-L1 (CD274) expression in human neuroblastoma cells
Boes, M. L., & Meyer‐Wentrup, F. A. G. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.027 · Cited by 72
Nightingale, Z. D., Patkar, C. G., & Rothman, A. L. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0208105 · Cited by 69
Immune Memory and Exhaustion: Clinically Relevant Lessons from the LCMV Model
Zehn, D., & Wherry, E. J. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-15774-0_10 · Cited by 68
Shaabani, N., Duhan, V., Khairnar, V., Gassa, A., Ferrer-Tur, R., Häussinger, D., Recher, M., Zelinskyy, G., Liu, J., Dittmer, U., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.350 · Cited by 65
The immunological function of extracellular vesicles in hepatitis B virus-infected hepatocytes
Kakizaki, M., Yamamoto, Y., Yabuta, S., Kurosaki, N., Kagawa, T., & Kotani, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205886 · Cited by 65
PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing
Akhmetzyanova, I., Drabczyk-Pluta, M., Neff, C. P., Sutter, K., Dietze, K. K., Werner, T., Liu, J., Chen, L., Lang, K. S., Palmer, B. E., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005224 · Cited by 64
Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling
Zhai, N., Li, H., Song, H., Yang, Y., Cui, A., Li, T., Niu, J., Crispe, I. N., Su, L., & Tu, Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170516 · Cited by 61
Wang, X., Zhang, Z., Zhang, S., Fu, J., Yao, J., Jiao, Y., Wu, H., & Wang, F. (2008) · European Journal of Immunology · doi:10.1002/eji.200838285 · Cited by 60
Planès, R., BenMohamed, L., Leghmari, K., Delobel, P., Izopet, J., & Bahraoui, E. (2014) · Journal of Virology · doi:10.1128/jvi.00825-14 · Cited by 58
CD8+ Resident Memory T Cells and Viral Infection
Wu, X., Wu, P., Shen, Y., Jiang, X., & Xu, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02093 · Cited by 58
Jones, D., Como, C. N., Jing, L., Blackmon, A. M., Neff, C. P., Krueger, O., Bubak, A. N., Palmer, B. E., Koelle, D. M., & Nagel, M. A. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007650 · Cited by 56
Channappanavar, R., Twardy, B. S., & Suvas, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039757 · Cited by 54
Viral Infection of Human Lung Macrophages Increases PDL1 Expression via IFNβ
Staples, K. J., Nicholas, B., McKendry, R., Spalluto, C. M., Wallington, J. C., Bragg, C. W., Robinson, E. C., Martin, K., Djukanović, R., & Wilkinson, T. M. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121527 · Cited by 53
Grakoui, A., Wherry, E. J., Hanson, H. L., Walker, C. M., & Ahmed, R. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.07.009 · Cited by 52
Müller, D. B., Raftery, M. J., Kather, A., Giese, T., & Schönrich, G. (2004) · European Journal of Immunology · doi:10.1002/eji.200324509 · Cited by 49
Self-citationImmune Exhaustion: Past Lessons and New Insights from Lymphocytic Choriomeningitis Virus
Kahan, S. M., & Zajac, A. J. (2019) · Viruses · doi:10.3390/v11020156 · Cited by 48
Xu, H., Wang, X., Pahar, B., Moroney‐Rasmussen, T., Alvarez, X. A., Lackner, A. A., & Veazey, R. S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001642 · Cited by 46
Menicucci, A. R., Versteeg, K. M., Woolsey, C. B., Mire, C. E., Geisbert, J. B., Cross, R. W., Agans, K. N., Jankeel, A., Geisbert, T. W., & Messaoudi, I. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01372 · Cited by 46
David, P., Megger, D. A., Kaiser, T., Werner, T., Liu, J., Chen, L., Sitek, B., Dittmer, U., & Zelinskyy, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00054 · Cited by 45
Check point inhibitors as therapies for infectious diseases
Cox, M. A., Nechanitzky, R., & Mak, T. W. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.07.016 · Cited by 42
Müller, A., Schmitt, L., Raftery, M., & Schönrich, G. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199811)28:11<3488::aid-immu3488>3.0.co;2-y · Cited by 40
Self-citationJeon, S., Leger, A. J. S., Cherpes, T. L., Sheridan, B. S., & Hendricks, R. L. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300582 · Cited by 40
Cited by
The Role of PD-1 in Acute and Chronic Infection
Jubel, J. M., Barbati, Z. R., Burger, C., Wirtz, D. C., & Schildberg, F. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00487 · Cited by 307
An aberrant STAT pathway is central to COVID-19
Matsuyama, T., Kubli, S. P., Yoshinaga, S. K., Pfeffer, K., & Mak, T. W. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-020-00633-7 · Cited by 289
PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment
Parvez, A., Choudhary, F., Mudgal, P., Khan, R., Qureshi, K. A., Farooqi, H., & Aspatwar, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1296341 · Cited by 216
Persistent cellular immunity to SARS-CoV-2 infection
Breton, G., Mendoza, P., Hägglöf, T., Oliveira, T. Y., Schaefer-Babajew, D., Gaebler, C., Turroja, M., Hurley, A., Caskey, M., & Nussenzweig, M. C. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20202515 · Cited by 129
COVID-19: more than a cytokine storm
Riva, G., Nasillo, V., Tagliafico, E., Trenti, T., Comoli, P., & Luppi, M. (2020) · Critical Care · doi:10.1186/s13054-020-03267-w · Cited by 46
Metadata
- Authors
- Schönrich, G., & Raftery, M. J.
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2019-06-13
- Volume
- 9
- Pages
- 207-207
- ISSN
- 2235-2988 (ISSN-L)
- OpenAlex
- W2951931980
- Cited by
- 275
- References
- 218
- FWCI
- 13.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.